ABSTRACT Four patients with cystic fibrosis diagnosed in middle and later life are presented. All had chronic bronchopulmonary infection with a high sweat sodium concentration, and chest radiographic evidence of upper zone bronchiectasis. Two patients had pancreatic dysfunction. Sputum culture grew mucoid Pseudomonas aeruginosa in three patients and Haemophilus influenzae in one. Ages at diagnosis were 63, 42, 40, and 35 years. These patients confirm the possibility of occasional longevity in cystic fibrosis and emphasise the need to consider the diagnosis at all ages. They also provide encouragement for younger patients.
The prognosis of cystic fibrosis has improved considerably over the post three decades. Previously death in the first year of life was common and very few patients with cystic fibrosis lived for more than 10 years. With the advent of systematic treatment with antibiotics and physiotherapy this outlook has changed and up to 75% of affected individuals are now reaching adult life. There are, however, some adult patients wvith cystic fibrosis with very mild, slowly progressive disease whose survival must be a reflection of the variable natural history of cystic fibrosis rather than the effects of treatment. In the past such patients are likely to have escaped diagnosis and some may be attending chest clinics unrecognised, or may still be undiagnosed in the community; the size of this population is unknown. The diagnosis of cystic fibrosis over the age of 30 years has been reported only rarely, although there are now many treated patients reaching this age.' 2 Newly diagnosed cystic fibrosis in middle and later life Case 2: woman aged 42 This woman had daily cough and sputum production from the age of 2, with frequent exacerbations resulting in many hospital admissions as a child. A shadow on her chest radiograph led to treatment with isoniazid and aminosalicylic acid (PAS) for one year. From the age of 5 she had frequent bowel motions and steatorrhoea and was started on a gluten free diet, to which she adhered incompletely. By her 20s she was taking a normal diet with no worsening of her symptoms. Over the last few years she had again had frequent pale stools, which were sometimes difficult to flush away; and she had been losing weight steadily for two years.
She had four pregnancies; the second child died in the neonatal period. After the birth of the fourth child when she was 35 her sputum production increased to a cupful a day with intermittent haemoptysis. At present she can walk up one flight of stairs and can cope with the housework. There is no family history of chest disease and she is a nonsmoker.
On examination she was thin. After a normal jejunal biopsy specimen was obtained she was treated with pancreatic extract (Pancrex V). Her bowel motions became normal and she gained 4 kg in weight. The diagnosis of cystic fibrosis depends on several features, including chronic bronchopulmonary infection, pancreatic insufficiency, a high sweat sodium concentration, and a family history of cystic fibrosis; not all patients have all these and in particular pancreatic insufficiency is absent in up to 15%.12 Stern et al have recently suggested modifications dividing the diagnostic criteria into major and minor criteria, following from their work on obstructive azoospermia."3 The diagnosis is established by the presence of one major with two minor or two major findings; the two criteria for diagnosis must include different organ systems. All our patients fulfill these criteria.
A sweat sodium concentration of over 60 mmol (mEq)/l in a child is usually considered diagnostic of cystic fibrosis, but sweat sodium concentrations tend to increase with age and show wide variability between individuals.'4 There are several series reporting-sweat sodium concentrations in normal people from older age groups.'5 16 In McKendrick's series of 110 normal adults only five had a concentration greater than 80 mmo/l.'4 Recent work by Hodson et al suggested that cystic fibrosis should be diagnosed in adults when two measurements of sweat sodium are above 70 mmolIl, and diagnostic accuracy was improved in borderline cases by a suppression test using fludrocortisone.9 All our patients had sweat sodium concentrations greater than 80 mmol/l and no suppression below 65 mmolll with 9-a-fludrocortisone occurred in the three patients in whom the test was done. When the baseline sweat sodium concentration was plotted against-the lowest concentration all results were well above the best discriminatory line as described by Hodson et al.9 The clinical pattern of chest disease in these patients was typical of cystic fibrosis. All had a long history of respiratory infections that started in childhood, the chest radiographs showed changes of bronchiectasis predominantly affecting the upper zones, and bacteria cultured from the sputum were also typical. All our patients had been attending specialist clinics for some years before the diagnosis of cystic fibrosis was made. This suggests that there must be many others in the clinic population who are as yet undiagnosed. Wood'7 looked at 24 emphysematous patients, of whom five had an abnormal sweat chloride concentration and impaired absorption of neutral fat; the mean chloride concentrations, however, were only on the borderline of abnormality. Karlish and Tarosky'8 made a search for cystic fibrosis in adults attending a chronic lung disease clinic and found that 11 of 33 adults previously diagnosed as having bronchitis, emphysema, asthma, or bronchiectasis had abnormally high sweat electrolyte concentrations that were consistent with cystic fibrosis and some also had abnormal bronchograms. It is uncertain how many, if any, of the patients from those two studies had cystic fibrosis. The patients we report have excellent positive evidence of cystic fibrosis and emphasise the need to consider this diagnosis in any patient with persistent unexplained chest infections, particularly if combined with malabsorption. A sweat test should form part of the diagnostic investigation regardless of the age of the patient.
Finally, these patients are important for two other reasons. Firstly, they confirm that longevity is possHunt, Geddes ible with cystic fibrosis, which should provide encouragement for younger patients; and secondly, the identification of long survivors may well contribute to an understanding of the aetiology and pathophysiology of the disease.
